50242-135 : Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate


NDC: 50242-135
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Actemra
Dosage Form: Intravenous Injection, Solution, Concentrate
Application #: BLA125276
Rev. Date: 


NDC Package Codes:

  • 50242-135-01: 1 VIAL, SINGLE‑USE IN 1 BOX (50242‑135‑01) > 4 ML IN 1 VIAL, SINGLE‑USE
  • 50242-135-04: 4 VIAL, SINGLE‑USE IN 1 BOX (50242‑135‑04) > 4 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Tocilizumab

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Interleukin 6 Receptor Antagonists [MoA]
  • Interleukin-6 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 50242-136 Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc.
  • 50242-137 Actemra 20 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc.
  • 50242-138 Actemra 180 mg/ml Subcutaneous Injection, Solution by Genentech, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-135 QR Code

< Prev: 50242-134Next: 50242-136 >

Related Discussions:

Swollen and tender legs from Actemra?
My wife has been on Actemra for about 6-7months now and her doctor says it's working, my wife disagrees. Due to her ... 5 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.